Ab |
Antibodies |
ADC |
Antibody-Targeted Cytotoxic Drug Conjugates |
ADCC |
Antibody-Dependent Cellular Cytotoxicity |
ADCP |
Antibody-Dependent Cellular Phagocytosis |
ALL |
Acute Lymphoblastic Leukemia |
AML |
Acute Myeloid Leukemia |
BCR |
B-cell Receptor |
BL |
Burkitt Lymphoma |
BSA |
Bovine Serum Albumin |
CAR |
Chimeric Antigen Receptor |
CDC |
Complement-Dependent Cytotoxicity |
DLBCL |
Diffuse Large B-cell Lymphoma |
EC |
European Commission |
EMA |
European Medicines Agency |
EPR |
Enhanced Permeability and Retention |
ESF |
European Science Foundation |
Fab |
Antigen-Binding Fragment |
FDA |
Food and Drug Administration |
HSA |
Human Serum Albumin |
ICI |
Immune Checkpoint inhibitor |
mAbs |
Monoclonal Antibodies |
MPS |
Mononuclear Phagocyte System |
MRI |
Magnetic Resonance |
NHL |
Non-Hodgkin Lymphoma |
NPs |
Nanoparticles |
PC |
Protein Corona |
PEG |
Polyethylene Glycol |
PET |
Positron Emission Tomography |
PLA |
Poly(Lactide) Acid |
PLC |
Poly(ε-Caprolactone) |
PLGA |
Poly(Lactide-co-Glycolide) Acid |
PMMA |
Poly(Methyl Methacrylate) |
PVA |
Polyvinyl Alcohol |
scFv |
Single-Chain Fragment Variable |
SWCNT |
Single-Walled Carbon Nanotube |
WHO |
World Health Organization |